¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"average life expectancy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® half-life ÇÑ±Û ¹Ý°¨±â
¼³¸í   
  ¾î¶² ¹°ÁúÀÌ ¿ÜºÎÀû ¿äÀÎ, ¶Ç´Â ³»ºÎÀû ¿äÀο¡ ÀÇÇØ¼­ ºÐÇØµÉ °æ¿ì¿¡ ±× ¹°ÁúÀÇ ¿ø·¡ÀÇ ¾ç¿¡¼­ ¹ÝÀÌ µÇ´Â µ¥ °É¸®´Â ½Ã°£.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average life expectancy
    Æò±Õ¿©¸í
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life expectancy
    ±â´ë¿©¸í
  • mean life expectancy
    Æò±Õ¿©¸í
  • expectancy
    1. ±â´ë, ¿¹Ãø 2. ±â´ë°ª
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • advanced cardiac life support
    »ó±Þ½ÉÀå¼Ò»ý¼ú, Àü¹®½ÉÀå¼Ò»ý¼ú
  • advanced pediatric life support
    »ó±Þ¼Ò¾Æ¼Ò»ý¼ú, Àü¹®¼Ò¾Æ¼Ò»ý¼ú
  • advanced trauma life support
    »ó±Þ¿Ü»ó¼Ò»ý¼ú, Àü¹®¿Ü»ó¼Ò»ý¼ú
  • basic life support
    ±âº»¼Ò»ý¼ú
  • basic trauma life support
    ±âº»¿Ü»ó¼Ò»ý¼ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • expectancy
    ±â´ë, ±â´ë°ª
  • life style disease
    »ýȰ½À°üº´
  • half-life
    ¹Ý°¨±â
  • life
    »ýȰ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average life expectancy
    Æò±Õ±â´ë¿©¸í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life expectancy
    ¿©¸í, ³²Àº¼ö¸í
  • mean life expectancy
    Æò±Õ¿©¸í
  • life expectancy
    ±â´ë¿©¸í
  • expectancy
    ±â´ë, ±â´ë°ª
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • abridged life table
    °£ÀÌ»ý¸íÇ¥
  • aerospace life support system
    ¿ìÁÖ»ý¸íÀ¯Áö°èÅë
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • basic life support
    ±âº»¼Ò»ý¼ú
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abridged life table
    °£ÀÌ»ý¸íÇ¥(˧ËöË×ËḬ̂).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • advanced trauma life support
    »ó±Þ ¿Ü»ó¼Ò»ý¼ú
  • aerospace life support system
    (Ç×°ø)¿ìÁÖ¿ë »ý¸íÀ¯Áö½Ã½ºÅÛ.
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • half-life
    ¹Ý°¨±â
  • phase of life problem
    ÀλýÁÖ±âÀÇ ¹®Á¦
  • physical half life
    ¹°¸®Àû ¹Ý°¨±â(ÚªìµîÜ ÚâÊõÑ¢).
  • physical half-life
    ¹°¸®Àû¹Ý°¨±â
  • quality of life
    »îÀÇ Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • expectancy of life
    ¿©¸í(ËçËÎ).
  • life expectancy
    ¼ö¸í.
  • mean life expectancy
    Æò±Õ¿©¸í(̰˻ËçËÎ).
  • average expectation of life
    Æò±Õ¿©¸í(̰˻ËçËÎ).
  • average length of life
    Æò±Õ¼ö¸í(̰˻ËÛËÎ).
  • expectancy
    ¿¹±â(ËçË»), ±â´ë(Ë»ËÀ).
  • average
    Æò±Õ(ÀÇ).
  • average count
    Æò±Õ¹ø¼ö(ÊÙËÑËà).
  • average deviation
    Æò±ÕÆíÂ÷(̰˻̰̤).
  • average dose
    Æò±Õ¿ë·®, Æò±ÕÁ¶»ç·®.
  • average length of stay
    Æò±Õ Àç¿øÀϼö
  • average molecular weight
    Æò±ÕºÐÀÚ·®.
  • average movement articulator
    º¸Åë ¿îµ¿ ±³ÇÕ±â.
  • average path
    Æò±ÕµµÁ¤(¡­Ô³ïï).
  • average value
    Æò±ÕÄ¡.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life cycle
    »ýȰ»ç
  • sylvatic life cycle
    ¹Ð¸²»ýȰȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biological half-life
    »ý¹°ÇÐÀû ¹Ý°¨±â(ßæÚªùÊîÜÚâÊõÑ¢)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • half-life
    ¹Ý°¨±â(ÚâÊõÑ¢)
  • life cycle
    "»ýȰ»ç(ßæüÀÞÈ),»ýȰÁÖ±â(ßæüÀñÎÑ¢)"
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â(Úª×âîÜÚâÊõÑ¢)
  • radioactive half-life
    ¹æ»ç¼º ¹Ý°¨±â(Û¯ÞÒàõÚâÊõÑ¢)
  • average affinity
    Æò±Õģȭ·Â (øÁгöÑûúÕô)
  • average binding number
    Æò±Õ°áÇÕ¼ö (øÁг̿ùêâ¦)
  • average intrinsic association constant
    Æò±Õ°íÀ¯¿¬ÇÕ»ó¼ö (øÁгͳêóæáùêßÈâ¦)
  • average molecular weight
    Æò±ÕºÐÀÚ·® (øÁгÝÂí­Õá)
  • molecular weight average
    ºÐÀÚ·® Æò±Õ(ÝÂí­ÕáøÁг)
  • number-average molecular weight
    ¹«Æò±ÕºÐÀÚ·®(ÙíøÁгÝÂí­Õá)
  • percentage average deviation
    "ÆÛ¼¾Æ®(¹éºÐÀ²,ÛÝÝÂ×Ë) Æò±ÕÆíÂ÷(øÁгø¶ó¬)"
  • viscosity-average molecular weight
    Á¡µµ(ïÄÓø)Æò±Õ ºÐÀÚ·®(øÁгÝÂí­Õá)
  • weight-average molecular weight
    ¹«°ÔÆò±Õ(øÁг) ºÐÀÚ·®(ÝÂí­Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±ÕÀÇ
  • number of signal average [=NSA]
    ½ÅÈ£Æò±Õȸ¼ö
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • effective half life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • half-life; half-time
    ¹Ý°¨±â
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
  • life threatening
    »ý¸íÀ» À§ÇùÇÏ´Â
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALE active life expectancy; allowable limits of error; amputated lower extremity
DEALE declining exponential approximation of life expectancy [method]
QALE quality-adjusted life expectancy
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
AWP airway pressure; any willing provider; average of the wholesale prices; average wholesale price
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LE Life expectancy
AEQ Alcohol Expectancy Questionnaire
AAPCC Adjusted Average Per Capita Cost
ARIMA Auto Regressive Integrated Moving Average
ARMA AutoRegressive Moving Average
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • expectancy of life
    ¿©¸í
  • life expectancy
    ¼ö¸í
    ¾î¶² ¿¬·É ¶Ç´Â ¿¬·ÉÃþÀÇ »ç¶÷ÀÌ ´õ »ì ¼ö ÀÖ´Â °¡´É¼ºÀÌ ÀÖ´Â ¿¬¼ö·Î¼­ Åë°èÀûÀÎ Æò±Õ¿¡ ±âÃÊÇÑ °Í.
  • mean life expectancy
    Æò±Õ ¿©¸í
  • average length of life
    Æò±Õ ¼ö¸í
  • average
    Æò±Õ, Æò±ÕÀÇ
  • average count
    Æò±Õ ¹ø¼ö
  • average dose
    Æò±Õ ¿ë·®, Æò±Õ Á¶»ç·®
  • average maintenance dose
    µð±âÅ»¸®½º Æò±Õ À¯Áö·®
  • average molecular weight
    Æò±Õ ºÐÀÚ·®
  • average value
    Æò±ÕÄ¡
  • number of signal average
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • time weighted average concentration
    ½Ã°£ °¡Áß Æò±Õ ³óµµ
  • abridged life table
    °£ÀÌ »ý¸íÇ¥
  • advanced cardiac life support
    ÀÌÂ÷ ¼Ò»ý¼ú, ÀÌÂ÷ ½ÉÆó¼Ò»ý¼ú
  • aerospace life support system
    ¿ìÁÖ¿ë »ý¸í À¯Áö ½Ã½ºÅÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
life expectancy <epidemiology> Longevity, the average length of life of individuals in a population.
(05 Dec 1998)
average <statistics> A value that represents the sum of values divided by the number of values in the set. It represents or summarises the relevant features of a set of values.
Origin: M.E. Averays, loss from damage to ship or cargo, fr. It. Avaris, fr. Ar. 'awariya, damaged goods, + damage
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
average megawatt <physics> One megawatt of capacity produced continuously over a period of one year. 1 MWa = 1 MW x 8760 hours/year = 8,760 Mwh = 8,760,000 kWh.
Acronym: MWa
(05 Dec 1998)
average pulse magnitude <physics> The amplitude of pulse averaged throughout its duration; identical with peak amplitude for a square wave or pulse without droop.
(05 Mar 2000)
law of average localization Visceral pain is most accurately localised in the least mobile viscera and least accurately in the most mobile.
(05 Mar 2000)
advanced life support Definitive emergency medical care that includes defibrillation, airway management, and use of drugs and medications.
Compare: basic life support.
(05 Mar 2000)
artificial life Artificial life (AL, alife) is a scientific discipline in whichresearchers study life by creating computer programs that recreatebiological systems from scratch.
(09 Oct 1997)
basic life support Emergency cardiopulmonary resuscitation, control of bleeding, treatment of shock, acidosis, and poisoning, stabilization of injuries and wounds, and basic first aid.
(05 Mar 2000)
biological half-life <biochemistry, biology> This is the time required for one-half of the total amount of a particular substance in a biological system to be consumed or broken down by biological processes when the rate of removal is approximately exponential.
Toxic chemicals with a long biological half-life (such as some pesticides) will tend to accumulate in the body and are, therefore, more likely to be harmful. A substance with a short biological half-life may still accumulate if a portion of it it becomes tightly bound to bone or other tissues, even if most of it is quickly cleared from the body.
(21 Mar 1998)
vegetative life The simple metabolic and reproductive activity of humans or animals, apart from the exercise of conscious mental or psychic processes.
(05 Mar 2000)
germ-free life Animals not contaminated by or associated with any foreign organisms.
(12 Dec 1998)
change of life Colloquialism for menopause, climacteric.
(05 Mar 2000)
RNA life <biology, molecular biology> A hypothetical life form lacking DNA and protein which may have existed on early earth and in which RNA served both a genetic coding and a catalytic function.
(23 Aug 1998)
physical half-life The time required for half the atoms of a radionuclide to undergo disintegration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life expectancy
    Æò±Õ ¿¹»ó ¼ö¸í
  • expectancy
    ±â´ë
  • average
    Æò±Õ,Æò±ÕÀÇ,º¸ÅëÀÇ,Æò±ÕÇÏ´Ù
  • DowJones average
    (Áõ±Ç)´Ù¿ì Á¸½º Æò±Õ(ÁÖ°¡)
  • DowJones industrial average
    ´Ù¿ì Á¸½º °ø¾÷ÁÖ(ÁÖ) Æò±Õ
  • average
    Æò±ÕÀÇ;Ç¥ÁØÀÇ;º¸ÅëÀÇ;ÇØ¼Õ-Æò±ÕÇÏ´Ù;Æò±Õ ...ÀÌ µÇ´Ù;(Áõ±Ç µûÀ§¸¦ ¸Å¸ÅÇÏ¿©)Æò±Õ°ªÀ» ³»¸®´Ù
  • earned run average
    (¾ß±¸)(Åõ¼öÀÇ)¹æ¾îÀ²
  • fielding average
    ¼öºñÀ²
  • general average
    °øµ¿ ÇØ¼Õ
  • grade point average
    (¹Ì)¼ºÀûÀÇ Æò±ÕÁ¡
  • gross average
    °øµ¿ ÇØ¼Õ
  • particular average
    ´Üµ¶ ÇØ¼Õ
  • petty average
    »ç¼ÒÇÑ ÇØ¼Õ
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á